α-dystroglycan is a laminin receptor involved in extracellular matrix assembly on myotubes and muscle cell viability

Journal of Cell Biology

Volumn 145, Issue 6, 1999, Pages 1325-1340

  Montanaro, Federica ^a   Lindenbaum, Michael ^a,b   Carbonetto, Salvatore ^a  

^a MONTREAL GENERAL HOSPITAL   (Canada)

^b Chromos Molecular Systems Inc   (Canada)

Author keywords

Apoptosis; Dystrophin associated proteins; Laminin

Indexed keywords

CHOLINERGIC RECEPTOR; DYSTROGLYCAN; INTEGRIN; LAMININ RECEPTOR; PROTEIN KINASE; SARCOGLYCAN; TRYPAN BLUE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL MEMBRANE PERMEABILITY; CELL PROLIFERATION; CELL VIABILITY; CHROMATIN CONDENSATION; CONTROLLED STUDY; EXTRACELLULAR MATRIX; MOUSE; MUSCLE CELL; MYOBLAST; MYOTUBE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; APOPTOSIS; CELL DIFFERENTIATION; CELL DIVISION; CELL FUSION; CELL MEMBRANE; CELL SIZE; CELL SURVIVAL; CELLS, CULTURED; CYTOSKELETAL PROTEINS; DYSTROGLYCANS; EXTRACELLULAR MATRIX; INTEGRINS; LAMININ; MEMBRANE GLYCOPROTEINS; MICE; MUSCLES; PROTEIN BINDING; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, CHOLINERGIC; RECEPTORS, LAMININ; RNA, ANTISENSE; SARCOGLYCANS; TRANSFECTION;

ANIMALIA;

EID: 0033553906     PISSN: 00219525     EISSN: None     Source Type: Journal    
DOI: 10.1083/jcb.145.6.1325     Document Type: Article

References (98)

1. Abrahamson, D.R., M.H. Irwin, P.L. St. John, E.W. Perry, M.A. Accavitti, L.W. Heck, and J.R. Couchman. 1989. Selective immunoreactivities of kidney basement membranes to monoclonal antibodies against laminin: localization of the end of the long arm and the short arms to discrete microdomains. J. Cell Biol. 109:3477-3491.
2. Aviezer, D., D. Hecht, M. Safran, M. Eisinger, G. David, and A. Yayon. 1994. Perlecan, a basal lamina proteoglycan, promotes basic fibroblast growth factor-receptor binding, mitogenesis, and angiogenesis. Cell. 79:1005-1013.
3. Belkin, A.M., and N.R. Smalheiser. 1996. Localization of cranin (dystroglycan) at sites of cell-matrix and cell-cell contact: recruitment to focal adhesion is dependent upon extracellular ligands. Cell Adhes. Commun. 4:281-296.
4. Blaschuk, K.L., and P.C. Holland. 1994. The regulation of α5β1 integrin expression in human muscle cells. Dev. Biol. 164:475-483.
5. Blaschuk, K.L., C. Guerin, and P.C. Holland. 1997. Myoblast αvβ3 integrin levels are controlled by transcriptional regulation of expression of the β3 subunit and down-regulation of β3 subunit expression is required for skeletal muscle cell differentiation. Dev. Biol. 184:266-277.
6. Bönnemann, C.G., R. Modi, S. Noguchi, Y. Mizuno, M. Yoshida, E. Gussoni, E.M. McNally, D.J. Duggan, C. Angelini, E.P. Hoffman, et al. 1995. β-sarcoglycan (A3b) mutations cause autosomal recessive muscular dystrophy with loss of the sarcoglycan complex. Nat. Genet. 11:266-273.
7. Bowe, M.A., K.A. Deyst, J.D. Leszyk, and J.R. Fallon. 1994. Identification and purification of an agrin receptor from Torpedo post-synaptic membranes: a heterodimeric complex related to the dystroglycans. Neuron. 12:1173-1180.
8. Brenman, J.E., D.S. Chao, H. Xia, K. Aldope, and D.S. Brendt. 1995. Nitric oxide synthase is complexed with dystrophin and absent from skeletal muscle sarcolemma in Duchenne muscular dystrophy. Cell. 82:743-752.
9. Brenman, J.E., D.S. Chao, S.H. Gee, A.W. McGee, S.E. Craven, D.R. Santillano, Z. Wu, F. Huang, H. Xia, M.F. Peters, et al. 1996. Interaction of nitric oxide synthase with the postsynaptic density protein PSD-95 and α1-syntrophin mediated by PDZ domains. Cell. 84:757-767.
10. Campanelli, J.T., S.L. Roberds, K.P. Campbell, and R.H. Scheller. 1994. A role for dystrophin associated glycoproteins and utrophin in agrin-induced AChR clustering. Cell. 77:663-674.
11. Campbell, K.P. 1995. Three muscular dystrophies: loss of cytoskeleton-extra-cellular matrix linkage. Cell. 80:675-679.
12. Campbell, K.P., and S.D. Kahl. 1989. Association of dystrophin and an integral membrane glycoprotein. Nature. 338:259-262.
13. Carbonetto, S., and M.H. Lindenbaum. 1995. The basement membrane of the neuromuscular junction: a synaptic mediatrix. Curr. Opin. Neurobiol. 5:596-605.
14. Carpenter, S., and G. Karpati. 1979. Duchenne muscular dystrophy: plasma membrane loss initiates muscle cell necrosis unless it is repaired. Brain. 102: 147-161.
15. Carrie, A., F. Piccolo, F. Leturcq, C. de Toma, K. Azibi, C. Beldjord, J.M. Vallat, L. Merlini, T. Voit, C. Sewry, et al. 1997. Mutational diversity and hot spots in the α-sarcoglycan gene in autosomal recessive muscular dystrophy (LGMD2D). J. Med. Genet. 34:470-475.
16. Chiba, A., K. Matsumura, H. Yamada, T. Inazu, T. Shimizu, S. Kusunoki, I. Kanazawa, A. Kobata, and T. Endo. 1997. Structures of sialylated O-linked oligosaccharides of bovine peripheral nerve α-dystroglycan. J. Biol. Chem. 272:2156-2162.
17. Chung, C.Y., and M.-S. Kang. 1990. Correlation between fibronectin and its receptor in chick myoblast differentiation. J. Cell. Physiol. 142:392-400.
18. Cohen, M.W., C. Jacobson, E.W. Godfrey, K.P. Campbell, and S. Carbonetto. 1995. Distribution of α-dystroglycan during embryonic nerve-muscle synaptogenesis. J. Cell Biol. 129:1093-1101.
19. Cohen, M.W., C. Jacobson, P.D. Yurchenco, G.E. Morris, and S. Carbonetto. 1997. Laminin-induced clustering of dystroglycan on embryonic muscle cells: comparison with agrin-induced clustering. J. Cell Biol. 136:1047-1058.
20. Collo, G., L. Starr, and V. Quaranta. 1993. A new isoform of the laminin receptor α7β1 is developmentally regulated in skeletal muscle. J. Biol. Chem. 268: 19019-19024.
21. Crosbie, R.H., J. Heighway, D.P. Venzke, J.C. Lee, and K.P. Campbell. 1997. Sarcospan, the 25-kDa transmembrane component of the dystrophin-glyco-protein complex. J. Biol. Chem. 272:31221-31224.
22. D'Amore, P.A., R.H. Brown, Jr., P.T. Ku, E.P. Hoffman, H. Watanabe, K. Arahata, T. Ishihara, and J. Folkman. 1994. Elevated basic fibroblast growth factor in the serum of patients with Duchenne muscular dystrophy. Ann. Neurol. 35:362-365.
23. de Melker, A.A., L.M. Sterk, G.O. Delwel, D.L. Fles, H. Daams, J.J. Weening, and A. Sonnenberg. 1997. The A and B variants of the α3 integrin subunit: tissue distribution and functional characterization. Lab. Invest. 76:547-563.
24. Dickson, G., A. Azad., G.E. Morris, H. Simon, M. Noursadeghi, and F.S. Walsh. 1992. Co-localization and molecular association of dystrophin with laminin at the surface of mouse and human myotubes. J. Cell Sci. 103:1223-1233.
25. Douville, P.J., W.J. Harvey, and S. Carbonetto. 1988. Isolation and partial characterization of high affinity laminin receptors in neural cells. J. Biol. Chem. 263:14964-14969.
26. Duclos, F., V. Straub, S.A. Moore, D.P. Venzke, R.F. Hrstka, R.H. Crosbie, M. Durbeej, C.S. Lebakken, A.J. Ettinger, J. van der Meulen, et al. 1998. Progressive muscular dystrophy in α-sarcoglycan-deficient mice. J. Cell Biol. 142:1461-1471.
27. Durbeej, M., E. Larsson, O. Ibraghimov-Beskrovnaya, S.L. Roberds, K.P. Campbell, and P. Ekblom. 1995. Non-muscle α-dystroglycan is involved in epithelial development. J. Cell Biol. 130:79-91.
28. Ervasti, J.M., and K.P. Campbell. 1991. Membrane organization of the dystrophin glycoprotein complex. Cell. 66:1121-1131.
29. Ervasti, J.M., and K.P. Campbell. 1993. A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin. J. Cell Biol. 122:809-823.
30. Foster, R.F., J.M. Thompson, and S.J. Kaufman. 1987. A laminin substrate promotes myogenesis in rat skeletal muscle cultures: analysis of replication and development using anti-desmin and anti-BrdUrd monoclonal antibodies. Dev. Biol. 122:11-20.
31. Gee, S.H., R.W. Blacher, P.J. Douville, P.R. Provost, P.D. Yurchenco, and S. Carbonetto. 1993. Laminin-binding protein 120 from brain is closely related to the dystrophin-associated glycoprotein, dystroglycan, and binds with high affinity to the major heparin binding domain of laminin. J. Biol. Chem. 268: 14972-14980.
32. Gee, S.H., F. Montanaro, M.H. Lindenbaum, and S. Carbonetto. 1994. Dystroglycan-α, a dystrophin-associated glycoprotein, is a functional agrin receptor. Cell. 77:675-686.
33. George-Weinstein, M., R.F. Foster, J.V. Gerhart, and S.J. Kaufman. 1993. In vitro and in vivo expression of α7 integrin and desmin define the primary and secondary myogenic lineages. Dev. Biol. 156:209-229.
34. Glass, D.J., D.C. Bowen, T.N. Stitt, C. Radziejewski, J. Bruno, T.E. Ryan, D.R. Gies, S. Shah, K. Mattson, S.J. Burden, et al. 1996. Agrin acts via a MuSK receptor complex. Cell. 85:513-523.
35. Graham, F.L., and A.J. Van der Eb. 1973. A new technique for the assay of infectivity of human adenovirus DNA. Virol. 52:456-467.
36. Guan, J.-L. 1997. Role of focal adhesion kinase in integrin signaling. Int. J. Biochem. 29:1085-1095.
37. Gullberg, D., G. Sjoberg, T. Veiling, and T. Sejersen. 1995. Analysis of fibronectin and vitronectin receptors on human fetal skeletal muscle cells upon differentiation. Exp. Cell Res. 220:112-123.
38. Hack, A.A., C.L. Ly, F. Jiang, C.J. Clendenin, K.S. Sigrist, R.L. Wollmann, and E.M. McNally. 1998. γ-Sarcoglycan deficiency leads to muscle membrane defects and apoptosis independent of dystrophin. J. Cell Biol. 142:1279-1287.
39. Henry, M.D., and K.P. Campbell. 1998. A role for dystroglycan in basement membrane assembly. Cell. 95:859-870.
40. Ibraghimov-Beskrovnaya, O., J.M. Ervasti, C.J. Leveille, C.A. Slaughter, S.W. Sernett, and K.P. Campbell. 1992. Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix. Nature. 355:696-702.
41. Jacobson, C., F. Montanaro, M. Lindenbaum, S. Carbonetto, and M. Ferns. 1998. Alpha-dystroglycan functions in acetylcholine receptor aggregation but is not a coreceptor for agrin-MuSK signaling. J. Neurosci. 18:6340-6348.
42. Jo, S.A., X. Zhu, M.A. Marchionni, and S.J. Burden. 1994. Neuregulins are concentrated at nerve-muscle synapses and activate ACh-receptor gene expression. Nature. 373:158-161.
43. Jung, D., B. Yang, J. Meyer, J.S. Chamberlain, and K.P. Campbell. 1995. Identification and characterization of the dystrophin anchoring site on β-dystroglycan. J. Biol. Chem. 270:27305-27310.
44. Jung, D., F. Duclos, B. Apostol, V. Straub, J.C. Lee, V. Allamand, D.P. Venzke, Y. Sunada, C.R. Moomaw, C.J. Leveille, et al. 1996a. Characterization of δ-sarcoglycan, a novel component of the oligomeric sarcoglycan complex involved in limb-girdle muscular dystrophy. J. Biol. Chem. 271:32321-32329.
45. Jung, D., F. Leturcq, Y. Sunada, F. Duclos, F.M S. Tome, C. Moomaw, L. Merlini, K. Azibi, M. Chaouch, C. Slaughter, et al. 1996b. Absence of γ-sarcoglycan (35 DAG) in autosomal recessive muscular dystrophy linked to chromosome 13q12. FEBS Lett. 381:15-20.
46. Klietsch, R., J.M. Ervasti, W. Arnold, K.P. Campbell, and A.O. Jorgensen. 1993. Dystrophin-glycoprotein complex and laminin colocalize to the sarcolemma and transverse tubules of cardiac muscle. Circ. Res. 72:349-360.
47. MacCalman, C.D., N. Bardeesy, P.C. Holland, and O.W. Blaschuk. 1992. Non-coordinate developmental regulation of N-cadherin, N-CAM, integrin, and fibronectin mRNA levels during myoblast terminal differentiation. Dev. Dyn. 195:127-132.
48. Matsuda, R., A. Nishikawa, and H. Tanaka 1995. Visualization of dystrophic muscle fibers in mdx mouse by vital staining with Evans blue: evidence of apoptosis indystrophin-deficient muscle. J. Biochem. 118:959-964.
49. Mayer, U., G. Saher, R. Fässler, A. Bornemann, F. Echtermeyer, H. von der Mark, N. Miosge, E. Pöschl, and K. von der Mark. 1997. Absence of integrin α7 causes a new form of muscular dystrophy. Nat. Genet. 17:318-323.
50. McNally, E.M., C.T. Ly, and L.M. Kunkel. 1998. Human ε-sarcoglycan is highly related to α-sarcoglycan (adhalin), the limb girdle muscular dystrophy 2D gene. FEBS Lett. 422:27-32.
51. Miyagoe, Y., K. Hanaoka, I. Nonaka, M. Hayasaka, Y. Nabeshima, K. Arahata, Y. Nabeshima, and S. Takeda. 1997. Laminin α2 chain-null mutant mice by targeted disruption of the Lama2 gene: a new model of merosin (laminin-2)-deficient congenital muscular dystrophy. FEBS Lett. 415:33-39.
52. Montanaro, F., S.H. Gee, C. Jacobson, M.H. Lindenbaum, and S. Carbonetto. 1998. Laminin and α-dystroglycan mediate acetylcholine receptor aggregation via a MuSK-independent pathway. J. Neurosci. 18:1250-1260.
53. Nigro, V., E. de Sa Moreira, G. Piluso, M. Vainzof, A. Belsito, L. Politano, A.A. Puca, M.R. Passos-Bueno, and M. Zatz. 1996. Autosomal recessive limb-girdle muscular dystrophy, LGMD2F, is caused by a mutation in the δ-sarcoglycan gene. Nat. Genet. 14:195-198.
54. Noguchi, S., E.M. McNelly, K.B. Othmane, Y. Hagiwara, Y. Mizuno, M. Yoshida, H. Yamamoto, C.G. Bönnemann, E. Gussoni, P.H. Denton, et al. 1995. Mutations in the dystrophin-associated protein γ-sarcoglycan in chromosome 13 muscular dystrophy. Science. 270:819-822.
55. Öcalan, M., S.L. Goodman, U. Kühl, S.D. Hauschka, and K. von der Mark. 1988. Laminin alters cell shape and stimulates motility and proliferation of murine skeletal myoblasts. Dev. Biol. 125:158-167.
56. Ohlendieck, K., J.M. Ervasti, J.B. Snook, and K.P. Campbell. 1991. Dystrophin-glycoprotein complex is highly enriched in isolated skeletal muscle sarcolemma. J. Cell Biol. 112:135-148.
57. Palmer, E.L., C. Ruegg, R. Ferrano, R. Pytela, and D. Sheppard. 1993. Sequence and tissue distribution of the integrin α9 subunit, a novel partner of β1 that is widely distributed in epithelia and muscle. J. Cell Biol. 123:1289-1297.
58. Patton, B.L., J.H. Miner, A.Y. Chiu, and J.R. Sanes. 1997. Distribution and function of laminins in the neuromuscular system of the developing, adult, and mutant mice. J. Cell Biol. 139:1507-1521.
59. Peng, H.B., A.A. Ali, D.F. Daggett, H. Rauvala, J.R. Hassell, and N.R. Smalheiser. 1998. The relationship between perlecan and dystroglycan and its implication in the formation of the neuromuscular junction. Cell Adhes. Commun. 5:475-489.
60. Peterson, G.L. 1977. A simplification of the protein assay method of Lowry et al. which is more generally applicable. Anal. Biochem. 83:346-356.
61. Roberds, S.L., F. Leturcq, V. Allamand, F. Piccolo, M. Jeanpierre, R.D. Anderson, L.E. Lim, J.C. Lee, F.M.S. Tomé, N.B. Romero, et al. 1994. Missense mutations in the adhalin gene linked to autosomal recessive muscular dystrophy. Cell. 78:625-633.
62. Rosalki, S.B. 1989. Serum enzymes in disease of skeletal muscle. Clin. Lab. Med. 9:767-781.
63. Rosen, G.D., J.R. Sanes, R. LaChance, J.M. Cunningham, J. Roman, and D.C. Dean. 1992. Roles for the integrin VLA-4 and its counter receptor VCAM-1 in myogenesis. Cell. 69:1107-1119.
64. Sambrook, J., E.F. Fritsch, and T. Maniatis. 1989. Molecular Cloning. A Laboratory Manual. 2nd Edition. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY. Section 1.53.
65. Sanes, J.R., E. Engvall, R. Butkowski, and D.D. Hunter. 1990. Molecular heterogeneity of basal laminae: isoforms of laminin and collagen IV at the neuromuscular junction and elsewhere. J. Cell Biol. 111:1685-1699.
66. Sastry, S.K., M. Lakonishok, D.A. Thomas, J. Muschler, and A.F. Horwitz. 1996. Integrin subunit ratios, cytoplasmic domains, and growth factor synergy regulate muscle proliferation and differentiation. J. Cell Biol. 133:169-184.
67. Sawtell, N.M., and J.L. Lessard. 1989. Cellular distribution of smooth muscle actins during mammalian embryogenesis: expression of the α-vascular but not the γ-enteric isoform in differentiating striated myocytes. J. Cell Biol. 109:2929-2937.
68. Schuler, F., and L.M. Sorokin. 1995. Expression of laminin isoforms in mouse myogenic cells in vitro and in vivo. J. Cell Sci. 108:3795-3805.
69. Shrivastava, A., C. Radziejewski, E. Campbell, L. Kovac, M. McGlynn, T.E. Ryan, S. Davies, M.P. Goldfarb, D.J. Glass, G. Lemke, and G.D. Yancopoulos. 1997. An orphan receptor tyrosine kinase family whose members serve as nonintegrin collagen receptors. Mol. Cell. 1:25-34.
70. Smalheiser, N.R., and N.B. Schwartz. 1987. Cranin, a laminin-binding protein of cell membranes. Proc. Natl. Acad. Sci. USA. 84:6457-6461.
71. Smalheiser, N.R., and E. Kim. 1995. Purification of cranin, a laminin-binding membrane protein: identity with dystroglycan and reassessment of its carbohydrate moieties. J. Biol. Chem. 270:15425-15433.
72. Spencer, M.J., C.M. Walsh, K.A. Dorshkind, E.M. Rodriguez, and J.T. Tidball. 1997. Myonuclear apoptosis in dystrophic mdx muscle occurs by perforin-mediated cytotoxicity. J. Clin. Invest. 99:2745-2751.
73. Straub, V., J.A. Rafael, J.S. Chamberlain, and K.P. Campbell. 1997. Animal models for muscular dystrophy show different patterns of sarcolemmal disruption. J. Cell Biol. 139:375-385.
74. Stromblad, S., J.C. Becker, M. Yebra, P.C. Brooks, and D.A. Cheresh. 1996. Suppression of p53 activity and p21WAF1/CIP1 expression by vascular cell integrin αvβ3 during angiogenesis. J. Clin. Invest. 98:426-433.
75. Sugiyama, J., D.C. Bowen, and Z.W. Hall. 1994. Dystroglycan binds nerve and muscle agrin. Neuron. 13:103-115.
76. 2J mice. Human Mol. Genet. 4:1055-1061.
77. Suzuki, A., M. Yoshida, K. Hayashi, Y. Mizuno, Y. Hagiwara, and E. Ozawa. 1994. Molecular organization at the glycoprotein-complex-binding site of dystrophin. Eur. J. Biochem. 220:283-292.
78. Tawil, N., M. Houde, R. Blacher, F. Esch, L.F. Reichardt, D.C. Turner, and S. Carbonetto. 1990. α1β1 integrin heterodimer functions as dual laminin/collagen receptor in neural cells. Biochemistry. 29:6450-6544.
79. Tews, D.S., and H.H. Goebel. 1997. DNA-fragmentation and expression of apoptosis-related proteins in muscular dystrophies. Neuropath. Appl. Neurobiol. 23:331-338.
80. Tian, M., C. Jacobson, S.H. Gee, K.P. Campbell, S. Carbonetto, and M. Jucker. 1996. Dystroglycan in the cerebellum is a laminin α2-chain binding protein at the glial-vascular interface and is expressed in Purkinje cells. Eur. J. Neurosci. 8:2739-2747.
81. Tidball, J.G., D.E. Albrecht, B.E. Lokensgard, and M.J. Spencer. 1995. Apoptosis precedes necrosis in dystrophin-deficienl muscle. J. Cell Sci. 108:2197-2204.
82. Timpl, R., H. Rohde, L. Risteli, U. Ott, P.G. Robey, and G.R. Martin. 1982. Laminin. Methods Enzymol. 82:831-838.
83. Vachon, P.M., F. Loechel, H. Xu, U.M. Wewer, and E. Engvall. 1996. Merosin and laminin in myogenesis; requirement for merosin in myotube stability and survival. J. Cell Biol. 134:1483-1479.
84. 1) in muscle function and survival: disrupted expression in merosin-deficient congenital muscular dystrophy. J. Clin. Invest. 100:1870-1881.
85. Vogel, W., G.D. Gish, F. Alves, and T. Pawson. 1997. The discoidin domain receptor tyrosine kinases are activated by collagen. Mol. Cell. 1:13-23.
86. von der Mark, H., and M. Öcalan. 1989. The differentiation and redifferentiation of myoblasts is triggered by fibronectin and laminin. Differentiation. 40: 150-157.
87. Wigler, M., A. Pellicer, S. Silverstein, R. Axel, G. Urlaub, and L. Chasin. 1979. DNA mediated transfer of the adenine-phosphoribosyltransferase locus into mammalian cells. Proc. Natl. Acad. Sci. USA. 76:1373-1376.
88. Williamson, R.A., M.D. Henry, K.J. Daniels, R.F. Hrstka, J.C. Lee, Y. Sunada, O. Ibraghimov-Beskrovnaya, and K.P. Campbell. 1997. Dystroglycan is essential for early embryonic development: disruption of Reichert's membrane in DAG1-null mice. Human Mol. Genet. 6:831-841.
89. Worton, R. 1995. Muscular dystrophies: Diseases of the dystrophin-glycoprotein complex. Science. 270:755-756.
90. Xu, H., P. Christmas, X.-R. Wu, U.M. Wewer, and E. Engvall. 1994. Defective muscle basement membrane and lack of M-laminin in the dystrophic dy/dy mouse. Proc. Natl. Acad. Sci. USA. 91:5572-5576.
91. Yamada, H., T. Shimizu, T. Tanaka, K.P. Campbell, and K. Matsumura. 1994. Dystroglycan is a binding protein of laminin and merosin in peripheral nerve. FEBS Lett. 352:49-53.
92. Yamada, H., A. Chiba, T. Endo, A. Kobata, L.V.B. Anderson, H. Hori, H. Fukuta-Ohi. I. Kanazawa, K.P. Campbell, T. Shimizu, and K. Matsumura 1996. Characterization of dystroglycan-laminin interaction in peripheral nerve. J. Neurochem. 66:1518-1524.
93. Yang, B., D. Jung, D. Motto, J. Meyer, G. Koretzky, and K.P. Campbell. 1995. SH3 domain-mediated interaction of dystroglycan and Grb2. J. Biol. Chem. 270:1-4.
94. Yoshida, M., and E. Ozawa. 1990. Glycoprotein complex anchoring dystrophin to sarcolemma. J. Biochem. (Tokyo). 108:748-752.
95. Yoshida, M., A. Suzuki, H. Yamamoto, S. Noguchi, Y. Mizuno, and E. Ozawa. 1994. Dissociation of the complex of dystrophin and its associated proteins into several unique groups by n-octyl-D-glucoside. Eur. J. Biochem. 222: 1055-1061.
96. Yoshida, T., Y. Pan, H. Hanada, Y. Iwata, and M. Shigekawa. 1998. Bidirectional signaling between sarcoglycans and the integrin adhesion system in cultured L6 myocytes. J. Biol. Chem. 273:1583-1590.
97. Yoshihara, C.M., and Z.W. Hall. 1993. Increased expression of the 43-kD protein disrupts acetylcholine receptor clustering in myotubes. J. Cell Biol. 122: 169-179.
98. Zhang, Z., K. Vuori, J.C. Reed, and E. Ruoslahti. 1995. The α5β1 integrin supports survival of cells on fibronectin and up-regulates Bcl-2 expression. Proc. Natl. Acad. Sci. USA. 92:6161-6165.